Filtered By:
Vaccination: Cervical Cancer Vaccine
Countries: Japan Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 12 results found since Jan 2013.

IJERPH, Vol. 19, Pages 5191: Effect of Different Educational Interventions on Knowledge of HPV Vaccination and Cervical Cancer among Young Women: A Preliminary Report
zunori Nagasaka The incidence and mortality rates of cervical cancer are rising among young women in Japan. In November 2021, the Japanese Ministry of Health, Labour, and Welfare reinstated the active recommendation for the human papillomavirus (HPV) vaccine, which was discontinued in June 2013 due to reports of adverse reactions, including chronic pain and motor dysfunction, following vaccination. However, vaccine hesitancy among the younger generation remains, and it is essential to identify the barriers in vaccination uptake. Therefore, we aimed to conduct a randomized study using different methods of providing educ...
Source: International Journal of Environmental Research and Public Health - April 25, 2022 Category: Environmental Health Authors: Yuko Takahashi Haruka Nishida Takayuki Ichinose Yuko Miyagawa Koichiro Kido Haruko Hiraike Hirono Ishikawa Kazunori Nagasaka Tags: Article Source Type: research

A nationwide epidemiological survey of adolescent patients with diverse symptoms similar to those following human papillomavirus vaccination: background prevalence and incidence for considering vaccine safety in Japan
CONCLUSION: Adolescent Japanese girls without HPV vaccination also visited hospitals with diverse symptoms similar to those following HPV vaccination. Our findings predicted the medical demands for diverse symptoms that are temporally associated with but not caused by vaccination of Japanese adolescents.PMID:34719583 | DOI:10.2188/jea.JE20210277
Source: Journal of Epidemiology - November 1, 2021 Category: Epidemiology Authors: Wakaba Fukushima Megumi Hara Yuri Kitamura Masahiko Shibata Yoshikazu Ugawa Koichi Hirata Akira Oka Shinya Miyamoto Susumu Kusunoki Satoshi Kuwabara Shuji Hashimoto Tomotaka Sobue Source Type: research

Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016
Conclusions South Korea should develop a system for proactively updating HPV  labels. These results also suggest potential research directions such as vaccination label expansion, pharmacovigilance studies, and identification of causality in AEs associated with HPV vaccination.
Source: International Journal of Clinical Pharmacy - July 15, 2019 Category: Drugs & Pharmacology Source Type: research

Efficacy, safety, and immunogenicity of a quadrivalent HPV vaccine in Japanese men: A randomized, Phase 3, placebo-controlled study.
CONCLUSIONS: Results suggest qHPV vaccine is efficacious against HPV6/11/16/18-related persistent infections, immunogenic, and well-tolerated in Japanese men. Clinical trial registration identifier: NCT01862874. PMID: 30797638 [PubMed - as supplied by publisher]
Source: Vaccine - February 20, 2019 Category: Allergy & Immunology Authors: Mikamo H, Yamagishi Y, Murata S, Yokokawa R, Han SR, Wakana A, Sawata M, Tanaka Y Tags: Vaccine Source Type: research

Adverse Event Reporting Patterns of Marketing Authorization Holders, Healthcare Professionals and Patients in Japan: Lessons Learnt From the Human Papilloma Virus Vaccine
ConclusionIn Japan, the characteristics of AEFI reports differed by source for HPV vaccines. MAH and HCP reports identified the major trend in AEFI occurrence during the early post-marketing phase, whereas patient reports in cooperation with HCPs facilitated the detection of weak signals of possible AEFIs throughout the product lifecycle. Patient reporting systems should be encouraged, especially by promoting the communication between patients and  local “home” pharmacies in cooperation with patient organizations.
Source: Pharmaceutical Medicine - March 19, 2018 Category: Drugs & Pharmacology Source Type: research

Suspected Adverse Effects After Human Papillomavirus Vaccination: A Temporal Relationship Between Vaccine Administration and the Appearance of Symptoms in Japan
ConclusionsThe period of human papillomavirus vaccination considerably overlapped with that of unique post-vaccination symptom development. Based on these sequential events, it is suggested that human papillomavirus vaccination is related to the transiently high prevalence of the previously mentioned symptoms including chronic regional pain syndrome and autonomic and cognitive dysfunctions in the vaccinated patients.
Source: Drug Safety - July 25, 2017 Category: Drugs & Pharmacology Source Type: research

Japanese Government Continues to Ban the MMR Vaccine
Conclusion Japanese officials have made decisions that value the health and safety of their citizens when they have removed vaccines with dangerous side effects from their national vaccination program. Japan boasts a low infant mortality rate, despite — or perhaps because of  — mandating only a fraction of the vaccines required by other developed countries, including the United States. If you wish to learn more about the harmful ingredients in vaccines or the potential adverse reactions, we have compiled an easy-to-navigate list of vaccine package inserts from the manufacturers that you can view or download he...
Source: vactruth.com - June 23, 2016 Category: Allergy & Immunology Authors: Missy Fluegge Tags: Logical Missy Fluegge Top Stories HPV Vaccine MMR vaccine truth about vaccines Vaccine Death Source Type: blogs